Pharmacokinetics of the Selective Glucocorticoid Receptor Modulator Miricorilant in Healthy Volunteers and Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Custodio et al. • 2024 • EASL 2024 Congress

Read more

Hypercortisolism Impact on Hypertension and Hyperglycemia and Beyond

Ralph A. DeFronzo • 2024 • Heart in Diabetes 2024
Posted with permission of the presenter.

Read more

Results From Grace, a Phase 3 Double-blind, Randomized-withdrawal Study of the Selective Glucocorticoid Receptor Modulator Relacorilant for the Treatment of Endogenous Hypercortisolism (Cushing Syndrome)

2024 • ENDO 2024

Read more

© 2024 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube